GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » COGS-to-Revenue

Yixintang Pharmaceutical Group Co (SZSE:002727) COGS-to-Revenue : 0.70 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co COGS-to-Revenue?

Yixintang Pharmaceutical Group Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥3,551 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥5,100 Mil.

Yixintang Pharmaceutical Group Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.70.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yixintang Pharmaceutical Group Co's Gross Margin % for the three months ended in Mar. 2024 was 30.36%.

Yixintang Pharmaceutical Group Co COGS-to-Revenue Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co COGS-to-Revenue Chart

Yixintang Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.64 0.63 0.65 0.67

Yixintang Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.66 0.68 0.67 0.70

Yixintang Pharmaceutical Group Co COGS-to-Revenue Calculation

Yixintang Pharmaceutical Group Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=11645.534 / 17380.311
=0.67

Yixintang Pharmaceutical Group Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3551.331 / 5099.518
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yixintang Pharmaceutical Group Co  (SZSE:002727) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yixintang Pharmaceutical Group Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3551.331 / 5099.518
=30.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Yixintang Pharmaceutical Group Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » COGS-to-Revenue
Comparable Companies
SHSE:603883 SZSE:301017 SZSE:301408 SHSE:605266 SZSE:002758 SZSE:002462 SZSE:002788 SZSE:300937 SZSE:301126 SHSE:600833 WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391
Traded in Other Exchanges
N/A
Address
No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500
Website
http://www.hx8886.com
Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.
Executives
Zhang Yong Directors, executives
Xiao Dong Lei Executives
Liu Qiong Director
Ruan Hong Xian Directors, executives
Guo Chun Li Director
Ruan Guo Wei Directors, executives
Li Zheng Hong Directors, executives
Zhao Biao Directors, executives
Tian Jun Directors, Directors, and Executives
Xu Ke Yi Director
Luo Yong Bin Executives
Zhou Hong Yun Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines